Master of Science in Pharmacology
Offered by Department of Pharmacology and Toxicology
Brief Description
This is a 2-year program which you can complete in 5 years.
Rationale and Objectives
In the 1960’s, the Master of Science in Pharmacology program was approved for implementation. It is one of the oldest institutional graduate programs of the University of the Philippines College of Medicine. The first revision was approved by the Board of Regents on February 27, 1992. In 2004, the Board of Regents approved the official change of name of the Department of Pharmacology to the Department of Pharmacology and Toxicology. This change was reflected in the scope of educational offerings within the department including the MS Pharmacology program. Thus, in 2006, under a new leadership in the Department, a revitalized program considering progress in the field of pharmacology and toxicology was implemented with new students accepted into the program.
As a leading academic and research institution in the Philippines offering an MS Pharmacology program, our graduates are expected to have advanced knowledge and skills in the multidisciplinary and/or specialized fields of pharmacology and toxicology. The program outcomes include the following:
PROGRAM OUTCOMES- Demonstrate advanced knowledge and skills in specialized or multidisciplinary fields of pharmacology and toxicology for their chosen professional practice and self-directed research.
- Apply developments in the specific field of practice in pharmacology and toxicology to determine applicability and utility in their practiced profession.
- Communicate scientific content in professional or technical forums and/or in various written media for public awareness and utilization of research output in pharmacology and toxicology.
- Act professionally and ethically with social responsibility.
- Generate knowledge and innovations in pharmacology and toxicology to address our national needs and/or the global community.
- Work independently toward lifelong learning in his/her practiced professional field in pharmacology and toxicology.
Highlights
Following decades of implementation of the current MS Pharmacology, we have recognized the need to create a more responsive program. It should be one that addresses the needs of prospective clients while incorporating the recent advances in the field of both pharmacology and toxicology and developing a sense of nationalism to improve human life.
The MSc in Pharmacology curriculum takes into consideration the United Nations Sustainable Development (UN SDG) Goal 3 which is to ”ensure healthy lives and promote well-being for all at all ages.” It is also aligned with UN SDG Goal 4 which is to “ensure inclusive and equitable quality education and promote lifelong learning opportunities for all”. It has been our earnest desire to streamline our course curriculum and program requirements in a manner most beneficial to the students while ensuring excellence in pursuit of the MS Pharmacology degree.
Admission Requirements
In general, there is no change in the admission requirements from the last revision approved by the Board of Regents in 1992 except for the removal of the required non- credit entry prerequisites. This program will remain open to holders of a Bachelor of Science degree or its equivalent and preferably with a background in biology, chemistry, mathematics, and physics. It is also open to holders of the degree of Doctor of Medicine and related sciences (e.g. Dentistry, Veterinary Medicine).
Admission requirements are submitted for evaluation to the NGOHS. Upon preliminary evaluation, there will be interview of the MS applicants and written exam (as necessary).
Contact Details
Department of Pharmacology and Toxicology
College of Medicine, University of the Philippines Manila
3F Salcedo Hall, 547 Pedro Gil Street, Ermita, Manila
Telephone: (632) 8526-4248
List of Faculty
Faculty | Position | Expertise | Course Coordinator/Lecturer | Lecturer in other Courses |
Cecilia A. Jimeno, MD |
Department Chair |
Internal Medicine, Endocrinology |
Pharma 299 Pharma 246 |
Pharma 204 Pharma 236 |
Lynn Crisanta R. Panganiban, MD |
Former Chair |
Family Medicine, Toxicology |
Pharma 248 |
Pharma 204 Pharma 257 Pharma 243 |
Irma R. Makalinao, MD, MA (PSS), PhD (Candidate) |
Past Chair, Adviser to the MS Program |
Pediatrics, Toxicology, Biosecurity expert |
Pharma 236 Pharma 297 |
Pharma 204 Pharma 255 Pharma 243 Pharma 246 |
Cecilia Nelia C. Maramba-Lazarte, MD, MScID, MScCT |
Assistant Chair for Research |
Pediatrics, Infectious Disease |
Pharma 257 Pharma 258 |
Pharma 204 Pharma 236 Pharma 220 Pharma 299 |
Stephanie Fay S. Cagayan, MD, PHD |
Vice Chair |
OB-Gyne, Trophoblastic diseases |
Pharma 234 Pharma 247 |
Pharma 204 Pharma 255 Pharma 257 Pharma 236 Pharma 248 Pharma 299 Pharma 246 |
Jose Paciano T. Reyes, MD |
Assistant Chair for Academics |
Internal Medicine, Neurology |
Pharma 241 Pharma 245 |
Pharma 204 Pharma 236 Pharma 220 Pharma 248 |
Connie Sison, MD |
Assistant Chair for Special Concerns |
Pediatrics, Cardiology |
Pharma 256 Pharma 243 |
Pharma 204 Pharma 236 |
Leonila A. Estole-Casanova, MD |
Assistant Chair for Services |
Obstetrics-Gynecology, Fertility |
Pharma 204 Pharma 255 |
Pharma 220 Pharma 248 Pharma 243 Pharma 246 |
Ailyn M. Yabes, MScPH, DrPH |
Graduate Program Coordinator |
Microbiology, Analytical Toxicology, Biosafety/Biosecurity |
Pharma 220 |
Pharma 204 Pharma 257 Pharma 297 Pharma 236 Pharma 234 Pharma 299 Pharma 243 |
Herbert Ho , MD |
Internal Medicine, Endocrinology |
Pharma 235 Pharma 244 |
Pharma 204 Pharma 256 Pharma 236 |
|
Other Faculty involved in team teaching | ||||
Nerissa M. Dando. MD |
Pediatrics, Adolescent Medicine, Toxicology |
Pharma 204 Pharma 243 |
||
Richard Henry P. Tiongco, MD |
Internal Medicine, Interventional Cardiology |
Pharma 204 Pharma 256 Pharma 236 |
||
Raymond V. Oliva, MD |
Internal Medicine, Hypertension expert |
Pharma 204 Pharma 256 Pharma 236 |
||
Danielle L. Sacdalan, MD, MSc |
Internist, Oncologist |
Pharma 236 |
||
Maria Stella Giron, MD, PhD |
Family Medicine, Geriatrics |
Pharma 204 Pharma 299 |
||
James Purificacion, MD |
Family Medicine, Herbal Medicine expert |
Pharma 220 |
||
Cynthia I. Valencia, MD |
Former Chair |
Chemistry, Clinical Pharmacology |
Special Topic Lecturer |
|
Nelia P. Cortes-Maramba, MD |
Professor Emeritus, Former Chair |
Pediatrics, Toxicology, Herbal Medicine expert |
Pharma 204 Pharma 220 Pharma 257 Special Topic Lecturer |
|
Cleotilde H. How, MD |
Professor Emeritus, Former Chair |
Pediatrics, Tuberculosis expert |
Pharma 204 |
|
Ernesto V. Valdez |
Professor Emeritus |
Special Topic Lecturer |
MSc in Pharmacology Course Offering
1st Sem | |
Core | |
Pharma 204 - Fundamentals of Pharmacology | (4 units: 3 units lec, 1 unit lab) |
Pharma 220 - Pharmacologic Techniques | (3 units lab) |
Major/Electives | |
Pharma 235-Biologic Fate of Drugs | (2 units lec) |
Pharma 297 – Seminars in Pharmacology and Toxicology | (1 unit seminar) |
Pharma 245- Advances in Autonomic Pharmacology | (2 units lec) |
Pharma 257 - Pharmacology of Herbal Medicine | (2 units lec) |
Pharma 234 – Advances in Molecular Pharmacology | (2 units lec) |
Pharma 256-Cardiovascular Pharmacology | (2 units Lec) |
Pharma 246 - Endocrine Pharmacology | (2 units lec) |
2nd Sem | |
Core | |
Pharma 248: Toxicology | (3 units: 2 units lec; 1 unit lab) |
Pharma 299: Research Methods in Pharmacology | (3 units lec) |
Major/Electives | |
Pharma 244: Clinical Pharmacology | (2 units lec) |
Pharma 236 – Advances in Comparative Pharmacology, Pharmacogenetics and Pharmacogenomics | (2 units lec) |
Pharma 241: Advances in Behavioral Pharmacology | (2 units: 1.5 units lec; 0.5 units lab) |
Pharma 258 - Pharmacology of Infectious Diseases | (2 units lec) |
Pharma 247 – Cancer Pharmacology | (2 units lec) |
Pharma 255 - Reproductive Toxicology | (2 units lec) |
Cognate: The students have the options to take courses under the list of electives as their cognate to comply with the 6 units required under the MS Pharmacology program. Biostat 301 (3 units) – suggested cognate
Msc in Pharmacology General Curriculum
Classification of Courses | Course Numbers and Course Titles | Units |
REQUIRED (Major CORE) |
|
13 |
ELECTIVES Students may choose 5 units from any of the following courses in this section |
|
5 |
Cognate | Any course outside of but related to the major discipline or field, which aims to complement or enrich the major courses. The students have the options to take courses under the list of electives as their cognate to comply with the 6 units required under the MS Pharmacology program | 6 |
Thesis Track | Following a GWA = 2.0 or better student may proceed to Pharma 300.1 followed by Pharma 300.2 Pharma 300.1: Thesis Writing (3 units) Pharma 300.2: Thesis Defense (3 Units) |
6 |
**The Master of Science in Pharmacology will be granted upon successful completion of 30 units (24 units of course work plus 6 units of thesis) with a GWA of 2.0 or better and timely submission of bound copies of approved thesis according to the prescribed format of UP Manila.